Joseph KI-ZERBO University, Ouagadougou, Burkina Faso.
African Institute of Public Health, Ouagadougou, Burkina Faso.
Pan Afr Med J. 2020 Oct 1;37:108. doi: 10.11604/pamj.2020.37.108.22384. eCollection 2020.
blood transfusion (BT) is an important part of pediatrics healthcare in sub-Saharan Africa because of anemia due to malaria, malnutrition and hereditary anomalies of red blood cells. However, BT services experienced chronic blood shortage, unsafe blood products and poor procedures of clinical use of blood. This results in inadequate management of severe anemia.
to assess the quality of BT requirements in severe malarial anemia at the regional hospital center of Koudougou in Burkina Faso, we carried out a cross-sectional study including 402 children with severe malaria (WHO 2000 criteria).
over the study period, severe malaria represented 45.6% (402/882) of pediatric admissions. Anemia was observed in 97.5% (392/402) of cases and BT was required for 78.4% (315/402). The median age was 16 months (IQR 9-27) and the average hemoglobin was 51.4±22.2 g/L. The prescriptions were in accordance with WHO and national guidelines respectively in 63.8% and 92.7%. Blood units were issued in 99.4% (350/352) of blood orderings. Out of 350 blood units delivered, blood was administered in 98% (343/350). The median actual time to transfusion was 65 minutes (IQR: 45-100) and median transfusion duration was 73.8 minutes (IQR: 47.5-110). The signs of intolerance to anemia disappeared in 134/138 cases (97.1%) and the average haemoglobin increased of 37.9±17.6 g/L. Death occurred in 23 cases (5.7%).
the management of severe malaria requires blood transfusion in almost half of cases. Blood was available to meet most requests. However, efforts are still required for proper use of the blood.
在撒哈拉以南非洲,由于疟疾、营养不良和红细胞遗传性异常导致的贫血,输血(BT)是儿科医疗保健的重要组成部分。然而,BT 服务一直面临着慢性血液短缺、不安全的血液制品以及临床用血程序不佳等问题。这导致严重贫血的管理不足。
为评估布基纳法索库杜古地区中心医院严重疟疾性贫血的 BT 需求质量,我们开展了一项横断面研究,纳入了 402 例符合世界卫生组织 2000 年标准的严重疟疾患儿。
在研究期间,严重疟疾占儿科住院患儿的 45.6%(402/882)。97.5%(392/402)的患儿存在贫血,78.4%(315/402)需要输血。中位年龄为 16 个月(IQR 9-27),平均血红蛋白为 51.4±22.2 g/L。处方分别符合世界卫生组织和国家指南的要求,占比分别为 63.8%和 92.7%。在 99.4%(350/352)的血液订单中发放了血液单位。在交付的 350 个血液单位中,有 98%(343/350)被使用。实际输血时间中位数为 65 分钟(IQR:45-100),输血时间中位数为 73.8 分钟(IQR:47.5-110)。138 例(97.1%)不耐受贫血症状消失,平均血红蛋白增加 37.9±17.6 g/L。23 例死亡(5.7%)。
近一半的严重疟疾病例需要输血治疗。血液供应能够满足大部分需求。然而,仍需要努力确保血液的合理使用。